YAS Healthcare signs contract for a Proteus®ONE solution, the first proton therapy system to be installed in Dubai, UAE

Core Insights - IBA has signed a contract with YAS Healthcare to install a ProteusONE compact proton therapy solution in Dubai, marking a significant advancement in cancer treatment in the UAE [1][2][4] - This installation will establish the first operational proton therapy center in the Gulf Cooperation Council (GCC) region, with patient treatments expected to commence in 2029 [2][4] - The contract includes the latest generation of proton therapy systems and a multi-year operation and maintenance agreement, with the typical price for such a system ranging between €35 million and €45 million [3][4] Company Overview - IBA is recognized as the world leader in particle accelerator technology and the leading provider of proton therapy solutions for cancer treatment [1][6] - The company is based in Louvain-la-Neuve, Belgium, and employs approximately 2,100 people globally, holding a B Corporation certification for social and environmental performance [6] - YAS Healthcare, a subsidiary of DAS Holding, is a prominent healthcare provider in Abu Dhabi, established in 2014, focusing on high-quality medical services [7]